FDA review remains neutral on boosters ahead of critical Friday vote even as Pfizer pushes additional shots

A highly-anticipated Food and Drug Administration review of evidence on whether a booster shot of the Pfizer-BioNTech coronavirus vaccine is widely necessary struck a noncommittal tone Wednesday.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news